Position in BMY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$560,469
-$51,064 QoQ
Shares Held
9,727
-3.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,468
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUE Private Wealth Advisors holds $27,309,850 across 8 Drug Manufacturers - General names. BMY ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,739 | $8,082,959 | |
| 2 | JNJ |
Johnson & Johnson
|
26,804 | $6,807,411 | |
| 3 | ABBV |
AbbVie Inc.
|
24,787 | $6,237,400 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,029 | $3,473,226 | |
| 5 | PFE |
Pfizer Inc
|
66,968 | $1,612,589 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
9,727 | $560,469 | |
| 7 | AMGN |
Amgen Inc
|
808 | $292,592 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,925 | $243,204 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $560,469 | 9,727 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $611,533 | 10,083 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $552,129 | 10,236 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $456,998 | 10,133 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $510,949 | 11,038 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $583,125 | 9,561 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $521,087 | 9,213 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $483,148 | 9,338 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $556,792 | 13,407 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $781,074 | 14,403 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $705,922 | 13,758 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $3,591,689 | 61,883 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,531,446 | 55,222 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,746,690 | 54,057 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,922,282 | 54,514 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,819,807 | 53,732 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $3,912,524 | 50,812 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $3,613,816 | 49,484 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $595,068 | 9,544 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $596,256 | 10,077 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $713,169 | 10,673 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $586,982 | 9,298 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $872,203 | 14,061 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $858,650 | 14,242 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $776,571 | 13,207 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $659,236 | 11,827 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||